Your browser doesn't support javascript.
loading
Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes.
Gabay, Cem; Burmester, Gerd R; Strand, Vibeke; Msihid, Jérôme; Zilberstein, Moshe; Kimura, Toshio; van Hoogstraten, Hubert; Boklage, Susan H; Sadeh, Jonathan; Graham, Neil M H; Boyapati, Anita.
Affiliation
  • Gabay C; University Hospitals of Geneva, Geneva, Switzerland.
  • Burmester GR; Charité - University Medicine Berlin, Berlin, Germany.
  • Strand V; Stanford University, Palo Alto, CA, USA.
  • Msihid J; Sanofi, Chilly-Mazarin, France.
  • Zilberstein M; Sanofi Genzyme, Bridgewater, NJ, USA.
  • Kimura T; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
  • van Hoogstraten H; Sanofi Genzyme, Bridgewater, NJ, USA.
  • Boklage SH; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
  • Sadeh J; Sanofi Genzyme, Bridgewater, NJ, USA.
  • Graham NMH; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
  • Boyapati A; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA. anita.boyapati@regeneron.com.
Arthritis Res Ther ; 22(1): 70, 2020 04 07.
Article in En | MEDLINE | ID: mdl-32264972
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Biomarkers / Cardiovascular Diseases / Bone Remodeling / Antibodies, Monoclonal, Humanized / Adalimumab Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Arthritis Res Ther Journal subject: REUMATOLOGIA Year: 2020 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Biomarkers / Cardiovascular Diseases / Bone Remodeling / Antibodies, Monoclonal, Humanized / Adalimumab Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Arthritis Res Ther Journal subject: REUMATOLOGIA Year: 2020 Document type: Article Affiliation country: